Literature DB >> 11353643

In vitro activities of terbinafine against Aspergillus species in comparison with those of itraconazole and amphotericin B.

C B Moore1, C M Walls, D W Denning.   

Abstract

Compared with the in vitro activities of itraconazole (geometric mean MIC [GM], 0.56 microg/ml) and amphotericin B (GM, 0.66 microg/ml), the in vitro activity of terbinafine was inferior against Aspergillus fumigatus (GM, 19.03 microg/ml) (P < 0.05) and superior against A. flavus (GM, 0.10 microg/ml), A. terreus (GM, 0.16 microg/ml), and A. niger (GM, 0.19 microg/ml). Clinical correlation is required, as trailing endpoints are problematic.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11353643      PMCID： PMC90563          DOI： 10.1128/AAC.45.6.1882-1885.2001

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  16 in total

1.  In vitro interaction of terbinafine with itraconazole against clinical isolates of Scedosporium prolificans.

Authors:  J Meletiadis; J W Mouton; J L Rodriguez-Tudela; J F Meis; P E Verweij
Journal:  Antimicrob Agents Chemother       Date:  2000-02       Impact factor: 5.191

2.  In vitro comparison of terbinafine and itraconazole against Penicillium marneffei.

Authors:  M R McGinnis; N G Nordoff; N S Ryder; G B Nunn
Journal:  Antimicrob Agents Chemother       Date:  2000-05       Impact factor: 5.191

3.  Lack of correlation of in vitro amphotericin B susceptibility testing with outcome in a murine model of Aspergillus infection.

Authors:  E M Johnson; K L Oakley; S A Radford; C B Moore; P Warn; D W Warnock; D W Denning
Journal:  J Antimicrob Chemother       Date:  2000-01       Impact factor: 5.790

4.  Refractory pulmonary aspergillosis: compassionate trial with terbinafine.

Authors:  G F Schiraldi; S L Cicero; M D Colombo; D Rossato; M Ferrarese; E Soresi
Journal:  Br J Dermatol       Date:  1996-06       Impact factor: 9.302

5.  In-vitro interaction of terbinafine with amphotericin B, fluconazole and itraconazole against clinical isolates of Candida albicans.

Authors:  F Barchiesi; L F Di Francesco; P Compagnucci; D Arzeni; A Giacometti; G Scalise
Journal:  J Antimicrob Chemother       Date:  1998-01       Impact factor: 5.790

6.  An evaluation of the in vitro activity of terbinafine.

Authors:  C J Jessup; N S Ryder; M A Ghannoum
Journal:  Med Mycol       Date:  2000-04       Impact factor: 4.076

7.  Activity of terbinafine against Pneumocystis carinii in vitro and its efficacy in the treatment of experimental pneumonia.

Authors:  C Contini; M Manganaro; R Romani; S Tzantzoglou; I Poggesi; V Vullo; S Delia; C De Simone
Journal:  J Antimicrob Chemother       Date:  1994-11       Impact factor: 5.790

Review 8.  Invasive aspergillosis caused by Aspergillus ustus: case report and review.

Authors:  P E Verweij; M F van den Bergh; P M Rath; B E de Pauw; A Voss; J F Meis
Journal:  J Clin Microbiol       Date:  1999-05       Impact factor: 5.948

9.  MIC and fungicidal activity of terbinafine against clinical isolates of Aspergillus spp.

Authors:  H J Schmitt; E M Bernard; J Andrade; F Edwards; B Schmitt; D Armstrong
Journal:  Antimicrob Agents Chemother       Date:  1988-05       Impact factor: 5.191

10.  Multiple-dose pharmacokinetics and distribution in tissue of terbinafine and metabolites.

Authors:  J M Kovarik; E A Mueller; H Zehender; J Denouël; H Caplain; L Millerioux
Journal:  Antimicrob Agents Chemother       Date:  1995-12       Impact factor: 5.191
View more
  15 in total

Review 1.  In vitro analyses, animal models, and 60 clinical cases of invasive Aspergillus terreus infection.

Authors:  William J Steinbach; John R Perfect; Wiley A Schell; Thomas J Walsh; Daniel K Benjamin
Journal:  Antimicrob Agents Chemother       Date:  2004-09       Impact factor: 5.191

Review 2.  Determination of fungicidal activities against yeasts and molds: lessons learned from bactericidal testing and the need for standardization.

Authors:  M A Pfaller; D J Sheehan; J H Rex
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

3.  In vitro activities of amphotericin B, terbinafine, and azole drugs against clinical and environmental isolates of Aspergillus terreus sensu stricto.

Authors:  Mariana S Fernández; Florencia D Rojas; María E Cattana; María de Los Ángeles Sosa; Cristina A Iovannitti; Cornelia Lass-Flörl; Gustavo E Giusiano
Journal:  Antimicrob Agents Chemother       Date:  2015-03-30       Impact factor: 5.191

4.  In Vitro Antifungal Activities against Moulds Isolated from Dermatological Specimens.

Authors:  Tzar Mohd Nizam; Rabiatul Adawiyah Ag Binting; Shafika Mohd Saari; Thivyananthini Vijaya Kumar; Marianayati Muhammad; Hartini Satim; Hamidah Yusoff; Jacinta Santhanam
Journal:  Malays J Med Sci       Date:  2016-05

Review 5.  Aspergillus fumigatus and aspergillosis: From basics to clinics.

Authors:  A Arastehfar; A Carvalho; J Houbraken; L Lombardi; R Garcia-Rubio; J D Jenks; O Rivero-Menendez; R Aljohani; I D Jacobsen; J Berman; N Osherov; M T Hedayati; M Ilkit; D James-Armstrong; T Gabaldón; J Meletiadis; M Kostrzewa; W Pan; C Lass-Flörl; D S Perlin; M Hoenigl
Journal:  Stud Mycol       Date:  2021-05-10       Impact factor: 16.097

6.  Incidence of Shiga toxin-producing Escherichia coli in diarrheic calves and its susceptibility profile to antimicrobials and Eugenia uniflora L.

Authors:  Marcelo F G Boriollo; Bianca S Moreira; Mateus C Oliveira; Taiane O Santos; Luciana R A Rufino; Nelma M S Oliveira
Journal:  Can J Vet Res       Date:  2021-01       Impact factor: 1.310

7.  Multilocus Phylogeny and Antifungal Susceptibility of Aspergillus Section Circumdati from Clinical Samples and Description of A. pseudosclerotiorum sp. nov.

Authors:  J P Z Siqueira; D A Sutton; J Gené; D García; N Wiederhold; S W Peterson; J Guarro
Journal:  J Clin Microbiol       Date:  2017-01-04       Impact factor: 5.948

8.  Molecular identification and antifungal susceptibilities of black Aspergillus isolates from otomycosis cases in Hungary.

Authors:  Gyöngyi Szigeti; Sándor Kocsubé; Ilona Dóczi; László Bereczki; Csaba Vágvölgyi; János Varga
Journal:  Mycopathologia       Date:  2012-02-23       Impact factor: 2.574

9.  Patterns of amphotericin B killing kinetics against seven Candida species.

Authors:  Emilia Cantón; Javier Pemán; Miguel Gobernado; Angel Viudes; Ana Espinel-Ingroff
Journal:  Antimicrob Agents Chemother       Date:  2004-07       Impact factor: 5.191

10.  The ototoxic effect of intratympanic terbinafine applied in the middle ear of rats.

Authors:  Mustafa Sagit; Mehmet Akıf Somdas; Ferhat Korkmaz; Alper Akcadag
Journal:  J Otolaryngol Head Neck Surg       Date:  2013-02-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.